nonprofit logo

Cancer Research Institute

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 131837442 ✦ New york, NY ✦ Designated as a 501(c)(3)

Overview

What is Cancer Research Institute?

The Cancer Research Institute (CRI) is a New York-based nonprofit organization dedicated to saving lives by fueling the discovery and development of effective immunotherapies for various types of cancer. They achieve this by funding laboratory, translational, and clinical research aimed at harnessing the power of the immune system for cancer diagnosis, treatment, and cure. The organization grants up to $200,000 over two years to qualified scientists investigating clinically relevant questions related to optimizing cancer immunotherapies. With a mission to advance immunology and immunotherapy, CRI also coordinates educational conferences and disseminates information on tumor immunology to the media, public, and scientific communities. The Cancer Research Institute employs a team of 36 individuals.


Official website here: www.cancerresearch.org

Is Cancer Research Institute legitimate?

Cancer Research Institute is a legitimate nonprofit organization registered as a 501(c)(3) entity. Cancer Research Institute submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

Here are some key statistics you may want to consider:

Executive Compensation: $2,513,200
Professional Fundraising Fees: $0
Other Salaries and Wages: $1,702,495

For more financial information, click here


Official website here: www.cancerresearch.org

What is the mission statement of Cancer Research Institute?

The Cancer Research Institute is dedicated to saving lives by driving the discovery and development of effective immunotherapies for various types of cancer. To accomplish this, the organization funds laboratory, translational, and clinical research aimed at utilizing the immune system to diagnose, treat, and cure cancer. The Cancer Research Institute also coordinates educational conferences on immunology and immunotherapy and disseminates information about advancements in tumor immunology to various communities. In summary, the Cancer Research Institute is a leading institute focused on fueling the advancement of immunotherapies to combat cancer and improve patient outcomes.


Official website here: www.cancerresearch.org

Who is the CEO of Cancer Research Institute?

Jill O'Donnell-Tormey is the Principal Officer of Cancer Research Institute. The CEO's salary of Cancer Research Institute is $500,953 and their total compensation is $564,003.


Official website here: www.cancerresearch.org

What is the revenue of Cancer Research Institute?

Cancer Research Institute's revenue in 2022 was $33,675,150.


Official website here: www.cancerresearch.org

Who are the executives of Cancer Research Institute and what are their salaries?

The average compensation at Cancer Research Institute during 2022 was $117,103. There are 36 employees and 340 volunteers at Cancer Research Institute.

Here are 48 key members and their salaries (Cancer Research Institute's CEO's salary is $500,953 and their total compensation is $564,003):

    Jill O'Donnell-Tormey Phd (Ceo/Dir. Of Scientific Affairs)
  • Compensation: $500,953
  • Related: $0
  • Other: $63,050

    • Alfred R Massidas (Cfo/Dir. Of Human Resources)
  • Compensation: $324,388
  • Related: $0
  • Other: $77,455

    • Lynne A Rapino (Chief Program Officer)
  • Compensation: $268,914
  • Related: $0
  • Other: $75,404

    • Jay R Campbell (Managing Dir. Of Cri Clinical Accelerator And Vent)
  • Compensation: $249,581
  • Related: $0
  • Other: $53,388

    • Sharon S Slade (Chief Marketing Officer)
  • Compensation: $244,521
  • Related: $0
  • Other: $53,960

    • Brian M Brewer (Chief Communications Officer)
  • Compensation: $200,270
  • Related: $0
  • Other: $54,190

    • Rupinder Kaur (Chief Information Officer)
  • Compensation: $174,281
  • Related: $0
  • Other: $51,354

    • Deanne T Marbach (Director Of Major Gifts)
  • Compensation: $136,458
  • Related: $0
  • Other: $47,364

    • Qing Hua Zhang (Controller)
  • Compensation: $133,888
  • Related: $0
  • Other: $47,133

    • Marla S Lawson (Assoc. Dir. Of Corporate And Foundation Relations)
  • Compensation: $119,981
  • Related: $0
  • Other: $45,778

    • Shasell Negron (Assoc. Dir. Of Community Fundraising)
  • Compensation: $110,151
  • Related: $0
  • Other: $40,228

    • Samik K Upadhaya (Asst. Dir. Of Scientific Affairs)
  • Compensation: $110,144
  • Related: $0
  • Other: $34,277

    • Alex Mishurov (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Alexander P Lynch (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Andrew K Tsai (Chairman) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Andrew M Paul (Vice Chairman) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Brian J Brille (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Diane Tuft (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Donald J Gogel (Vice Chairman) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Edgar R Berner (Vice Chairman) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Frank Vsica (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Geoffrey O Coley (Treasurer) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Glenn J Desimone (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Jacques C Nordeman (Vice Chairman (Thru 11/21)) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • James A Stern (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Jim Weiss (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Lauren Sveronis (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Lief D Rosenblatt (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Margot E Freedman (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Michael B Targoff (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Michael J Petrick (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Michael M Kellen (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Michael R Crawford (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Mitra Lohrasbpour (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Oliver R Grace Jr (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Paul C Shiverick (Chairman) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Peter L Bloom (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Peter Zhou (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Robert S Stolar (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Ronald G Weiner (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Sandra Coudert Graham (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Sarah Kim (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Sean P Fahey (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Thomas G Mendell (Secretary) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Tony Alvarez Ii (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • W Robert Dahl (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • William S Goldberg (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Yacov Arnopolin (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0


  • Official website here: www.cancerresearch.org

    Where can I find the form 990 for Cancer Research Institute?

    The Cancer Research Institute’s most recent form 990 was submitted in 2022 and can be accessed here


    Official website here: www.cancerresearch.org

    Learn more at the official website: www.cancerresearch.org

    Mission Statement of Cancer Research Institute

    Cancer Research Institute (CRI) is a mission-driven organization dedicated to saving lives by fueling the discovery and development of effective immunotherapies for all types of cancer. To accomplish this noble goal, CRI invests in laboratory, translational, and clinical research aimed at harnessing the power of the immune system to diagnose, treat, and ultimately cure cancer.

    CRI's relentless pursuit of innovation extends beyond the walls of research facilities. The institute also coordinates scientific, medical, and patient education conferences on immunology and immunotherapy, and disseminates crucial information about advances in tumor immunology to various communities. This includes the media, the public, and the medical and scientific spheres, ensuring that knowledge about these groundbreaking developments is widely accessible.

    In essence, Cancer Research Institute is a beacon of hope in the fight against cancer. By funding research and fostering collaboration, CRI is igniting the flame of innovation that drives the scientific community to unlock the keys to diagnosing, treating, and curing this complex disease. Through their unwavering commitment to excellence and their dedication to sharing knowledge, CRI is making a significant impact on the lives of cancer patients and their loved ones.

    Impact

    This information is meant to be a general summary of Cancer Research Institute. Please take the time to review official sources before making any decisions based upon the content provided here.




    Thursday, August 15, 2024

    The Cancer Research Institute's impact lies in its mission to save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. Through initiatives like the Clinic and Laboratory Integration Program (CLIP), the institute supports qualified scientists in exploring clinically relevant questions to improve the effectiveness of cancer immunotherapies. By funding basic, preclinical, and translational research, the Cancer Research Institute provides up to $200,000 over two years to drive advancements in cancer immunotherapy that can be directly applied in clinical settings. Through these efforts, the institute aims to harness the power of the immune system to diagnose, treat, and ultimately cure cancer, while also facilitating scientific, medical, and patient education conferences on immunology and immunotherapy. The Cancer Research Institute's commitment to advancing medical research is evident in its contributions to the field of tumor immunology, disseminating information in English and Spanish to the media, public, and medical and scientific communities.





    Financials

    This financial information is from Propublica.

    Revenue
    Expenses
    Efficiency

    Other financial information:

    This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $4,910,453
  • Program Service Revenue: $0
  • Gross Receipts: $42,321,525

    • Assets and Liabilities:
  • Total Assets: $130,438,312
  • Total Liabilities: $63,733,550
  • Net Assets: $66,704,762
  • Organization Details

    Founding Year

    1953

    Principal Officer

    Jill O'Donnell-Tormey

    Main Address

    29 BROADWAY 4TH FLOOR, NEW YORK, NY, 10006

    NTEE Category

    Code: H300 - Medical research

    If you are a representative of Cancer Research Institute and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.